The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

Protein powders may seem like a convenient way to get extra nutrients, but they also have some potential risks to be aware of.

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear ...

Share on Pinterest Researchers believe that high doses of semaglutide may reduce blood flow to the optic nerve, which could lead to eye stroke. Maria Korneeva/Getty Images A new study has found that ...

Decades of climate research and data have yielded expanded understanding of how greenhouse gases affect the climate. This fast-track study will review the latest scientific evidence on whether ...

Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

Mounjaro - the brand name for tirzepatide - has become one of the most talked-about medications in metabolic health, and for good reason. But the conversation around it has gotten tangled up with ...

Peptides are short-chain amino acids that make up proteins. Taking peptide supplements may stimulate the body to secrete hormones, grow muscle tissue, and perform other functions. Possible benefits of ...